Tetrahydroindazoles and medical uses thereof

US10889564B2 · kind B2 · utility

Assignee

• Genase Therapeutics B.V. · NL

Inventors

• Sonia Lain · Stockholm, SE
• Catherine Drummond · Memphis, US
• Ingeborg Van Leeuwen · Stockholm, SE
• Martin Haraldsson · Täby, SE
• Lars Johansson
• Lars Sandberg · Stockholm, SE
• Ulrika Yngve · Uppsala, SE

Key dates

• Filing date: Nov 1, 2016
• Grant date: Jan 12, 2021
• Expiry date: Nov 1, 2036

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

There is herein provided a compound of formula I (I) or a pharmaceutically acceptable salt thereof, for use in the treatment of cancer and/or the treatment or prevention of a viral infection, wherein A1, A2, L1, R1, R2 and n have meanings as provided in the description.